Analysts predict significant upside for select stocks, with potential returns ranging from 13% to 43%. Divi’s Laboratories is poised to benefit from its involvement in diabetes and weight loss drugs. Devyani International’s acquisition of Sky Gate Hospitality is expected to boost its QSR business, while Anant Raj’s data center plans drive its growth despite revised timelines.
Vikas Khemani bets big on IndiGo, BHEL, and PSU banks amid market volatility
Vikas Khemani of Carnelian Asset Management outlines his investment strategy amid market volatility. He favors mid and large-cap stocks, with selective contra plays like IndiGo.